Skip to main content
Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone
HomeStocksAkums Drugs & Pharmaceuticals Ltd
Akums Drugs & Pharmaceuticals Ltd

Akums Drugs & Pharmaceuticals Ltd

Symbol:AKUMS
Small Cap
LTP₹680.2
-13.85 (-2%)
No chart data available for selected period

Fundamentals Ratios

Key Valuation Metrics

Market Cap₹10,901.11 Cr
P/E Ratio37.24
P/B Ratio4.49
Industry Ratio35.97
ROE7.70%
EPS (TTM)₹18.6
Dividend Yield0.42%
Book Value₹154.29
Face Value₹2
Sector P/E35.97
Outstanding Shares15.74 Cr
Beta0.88
Market Cap Type- -

Financial Statements

ParticularsMAR 2025MAR 2024MAR 2023MAR 2022
Sales Turnover4,118.164,178.183,654.823,671.89
Other Income68.8234.0390.0722.83
Total Revenue4,188.634,199.873,720.853,782.46
Total Expenditure3,655.324,068.893,411.53,864.33
Operating Profit533.3130.97309.36(81.86)
Interest34.650.6146.2516.66
Gross Profit498.780.36263.11(98.52)
Depreciation153.45125.64112.8194.68
Profit Before Tax0.00.00.00.0
Tax0.00.00.00.0
Net Profit0.00.00.00.0

About

Managing DirectorSANJEEV JAIN
Auditor NameWalker Chandiok & Co LLP
Founded2004
Parent OrganizationAkums Drugs & Pharmaceuticals Ltd

Price Summary

Open

₹680.1

Prev Close

₹694.05

Today's High

₹695.25

Today's Low

₹675

52W High₹838.8
52W Low₹409.3
Volume3,02,529
Traded ValueN/A

Shareholding Pattern

Foreign Promoters and Groups
Indian Promoters and Groups
Non-Promoter Institutions
Non-Promoter Non-Institutions

Data as per latest exchange filings*

Frequently Asked Questions

Common questions about this stock, answered from live data

As of 22 Oct 2026, 3:30 pm, the share price of Akums Drugs & Pharmaceuticals Ltd (AKUMS) is ₹680.2 on NSE and BSE.

Disclaimer: The FAQs above are generated based on historical and real-time market data provided by exchanges. This information is for educational purposes only and does not constitute financial advice, buy/sell recommendations, or price targets. Investment in the securities market is subject to market risks. Read all related documents carefully before investing.